Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study
- 25 November 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 103 (2), 243-250
- https://doi.org/10.1007/s12185-015-1915-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trialHaematologica, 2011
- Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric PopulationTransplantation and Cellular Therapy, 2010
- Mesenchymal stem cell as salvage treatment for refractory chronic GVHDBone Marrow Transplantation, 2010
- Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use StudyTransplantation and Cellular Therapy, 2010
- Prochymal Improves Response Rates In Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-GVHD) Involving The Liver And Gut: Results Of A Randomized, Placebo-Controlled, Multicenter Phase III Trial In GVHDTransplantation and Cellular Therapy, 2010
- Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled StudyTransplantation and Cellular Therapy, 2010
- Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumBone Marrow Transplantation, 2008
- Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantationBlood Cells, Molecules, and Diseases, 2008
- How I treat refractory acute GVHDBlood, 2007
- Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host DiseaseTransplantation, 2006